1. Welsh, Joshua A, Goberdhan, Deborah C I, O'Driscoll, Lorraine, Théry, Clotilde, Witwer, Kenneth W. . Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. In Journal of extracellular vesicles, 13, e12404. doi:10.1002/jev2.12404. https://pubmed.ncbi.nlm.nih.gov/38326288/
2. Li, Zhenyang, Zhou, Ye, Jia, Kaiwei, Cao, Xuetao, Hou, Jin. 2022. JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis. In Journal of hematology & oncology, 15, 161. doi:10.1186/s13045-022-01381-6. https://pubmed.ncbi.nlm.nih.gov/36333807/
3. Märkle, Hanna, Saur, Isabel M L, Stam, Remco. . Evolution of resistance (R) gene specificity. In Essays in biochemistry, 66, 551-560. doi:10.1042/EBC20210077. https://pubmed.ncbi.nlm.nih.gov/35612398/
4. Weiß, Claudia, Ziegler, Andreas, Becker, Lena-Luise, von der Hagen, Maja, Kaindl, Angela M. 2021. Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study. In The Lancet. Child & adolescent health, 6, 17-27. doi:10.1016/S2352-4642(21)00287-X. https://pubmed.ncbi.nlm.nih.gov/34756190/
5. Yang, Haoran, Deng, Qingmei, Ni, Tun, Wang, Hongzhi, Yang, Wulin. 2021. Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer. In International journal of biological sciences, 17, 4207-4222. doi:10.7150/ijbs.64714. https://pubmed.ncbi.nlm.nih.gov/34803493/
6. Weiß, Claudia, Becker, Lena-Luise, Friese, Johannes, Johannsen, Jessika, Ziegler, Andreas. 2024. Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study. In The Lancet regional health. Europe, 47, 101092. doi:10.1016/j.lanepe.2024.101092. https://pubmed.ncbi.nlm.nih.gov/39434961/
7. Xie, Ying, Huang, Yu, Li, Zhi-Yong, Yin, Zhinan, Lin, Xue-Jia. 2024. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells. In Molecular cancer, 23, 95. doi:10.1186/s12943-024-02001-2. https://pubmed.ncbi.nlm.nih.gov/38720319/
8. de Groot, Pieter, Nikolic, Tanja, Pellegrini, Silvia, Roep, Bart, Nieuwdorp, Max. 2020. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. In Gut, 70, 92-105. doi:10.1136/gutjnl-2020-322630. https://pubmed.ncbi.nlm.nih.gov/33106354/
智鼠故事 
